There are 2789 resources available
Introduction
Presenter: Martijn Lolkema
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Webcast
Role of lineage plasticity in response and resistance to therapies
Presenter: Himisha Beltran
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
Recapitulating human cancer through organoid models: Therapeutic implications of cellular heterogeneity
Presenter: Jeanine Roodhart
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
How representative mouse models can provide insights to therapeutic vulnerabilities
Presenter: Katerina Politi
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
Using repeated diagnostic leukapheresis to dissect resistance to treatment
Presenter: Martijn Lolkema
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
Introduction
Presenter: Paul Baas
Session: Targeting KRAS in lung cancer: Progress and next steps
Resources:
Slides
Current status of G12C inhibitors
Presenter: Colin Lindsay
Session: Targeting KRAS in lung cancer: Progress and next steps
Resources:
Slides
Webcast
Mechanisms of resistance
Presenter: Piro Lito
Session: Targeting KRAS in lung cancer: Progress and next steps
Resources:
Slides
Webcast
All things KRAS not G12C
Presenter: Chiara Ambrogio
Session: Targeting KRAS in lung cancer: Progress and next steps
Resources:
Slides
Webcast
Combinations including KRAS inhibitors
Presenter: Natasha Leighl
Session: Targeting KRAS in lung cancer: Progress and next steps
Resources:
Slides
Webcast